Situation Report

Liberia's president calls for more investment in health systems, news article, op-ed

ASSOCIATED PRESS                               Oct. 20, 2014

by Jonathan Paye-Layleh

Monrovia, Liberia — Liberian President Ellen Johnson Sirleaf said Ebola has killed more than 2,000 people in her country and has brought it to “a standstill,” noting that Liberia and two other badly hit countries were already weakened by years of war.

Appealing for more international help, Sirleaf described the devastating effects of Ebola in a “Letter to the World” that was broadcast Sunday by the BBC.   https://soundcloud.com/bbc-world-service/a-letter-to-the-world-on-ebola-from-liberian-president-ellen-johnson-sirleaf?ocid=socialflow_twitter

“Across West Africa, a generation of young people risk being lost to an economic catastrophe as harvests are missed, markets are shut and borders are closed,” the Nobel Peace Prize laureate said. “The virus has been able to spread so rapidly because of the insufficient strength of the emergency, medical and military services that remain under-resourced....”

ROUNDUP OF DEVELOPMENTS SUNDAY

REUTERS                                     Oct 19, 2014

By Erwin Seba

GALVESTON Texas --(Reuters) - The United States will issue strict new guidelines telling American health workers to cover their skin and hair when dealing with Ebola patients, a top health official said on Sunday, while some of the dozens of people being watched for possible exposure to the virus are expected to be cleared.

 A health care worker receives protocol on the proper removal of personal protection equipment from Centers for Disease Control and Prevention (CDC) instructors in preparation for the response to the current Ebola outbreak, during a CDC safety training course in Anniston, Alabama, October 6, 2014. Credit: Reuters/Tami Chappell

In Texas, a lab worker who spent much of a Caribbean holiday cruise in isolation tested negative for the deadly virus and left the Carnival Magic liner with other passengers after it docked at Galveston early on Sunday morning....

Image: An experimental Ebola vaccine has been developed by the U.S. National Institutes of Health and pharmaceutical company GlaxoSmithKline. Photograph by Steve Parsons, AP

news.nationalgeographic.com - October 14th, 2014 - Karen Weintraub

Ebola vaccines are so effective in monkeys that macaques can be protected or rescued even if they're injected with a hundred times the lethal dose of the Ebola virus after vaccination. But no one knows for certain whether the vaccines will work in humans; the vaccines haven't yet been rigorously tested in people.

Just developing the vaccines to test in monkeys was a grueling, decades-long process that has killed scores of macaques since the 1990s.

(VIEW COMPLETE ARTICLE)